More than 4,300 human genes have been patented by private companies or academics. But yesterday, a Federal District Court in Manhattan ruled that Myriad, a biopharmaceutical company, could no longer hold the patent on several genes, including two that are closely associated with breast and ovarian cancer. The ruling has reignited an ethical debate over whether a gene - something that exists naturally and in every human - can become intellectual property. 

UPDATED 6:15 p.m

Alex Goldmark here picking up the evening shift. 

We're watching a few different stories in the running for tomorrow's show. First up, is a nagging curiosity we've had for a few days now. A smattering of local press a few days back labelled Memphis the hunger capital of America. We're finding out why Memphis stands out. 

It occured to us that if it is such an enormous undertaking to pull off the US census, what is it like in India where they have more than a billion people? Well it takes more than two million census workers for one. 

And we'll have  another installment of our value series with Farai Chideya looking at how the changing economy has changed people's moral outlook in some way.